CD4 and primary progressive multiple sclerosis: Since specifically the kinetics of CSF recruitment of B cells and CD20dim CD4+ T cells are affected by OCR, we conclude that these cell types are more likely to contribute to the therapeutic effects of OCR in people with primary progressive multiple sclerosis compared with CD8+ T cells.